G Friman

1.6k total citations
52 papers, 1.2k citations indexed

About

G Friman is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Genetics. According to data from OpenAlex, G Friman has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 10 papers in Epidemiology and 10 papers in Genetics. Recurrent topics in G Friman's work include Viral Infections and Immunology Research (20 papers), Exercise and Physiological Responses (7 papers) and Cardiovascular Effects of Exercise (6 papers). G Friman is often cited by papers focused on Viral Infections and Immunology Research (20 papers), Exercise and Physiological Responses (7 papers) and Cardiovascular Effects of Exercise (6 papers). G Friman collaborates with scholars based in Sweden, United States and Finland. G Friman's co-authors include Jan Fohlman, N.‐G. Ilbäck, Hans Diderholm, Gun Frisk, Lars Wesslén, Torsten Tuvemo, W. R. Beisel, Anders Lannergård, Jouko Karjalainen and Karlis Pauksen and has published in prestigious journals such as Circulation, The Journal of Immunology and American Journal of Clinical Nutrition.

In The Last Decade

G Friman

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Friman Sweden 23 440 246 220 186 167 52 1.2k
Göran Friman Sweden 26 462 1.1× 155 0.6× 359 1.6× 179 1.0× 245 1.5× 91 1.8k
Charles E. Wiedmeyer United States 23 203 0.5× 182 0.7× 73 0.3× 69 0.4× 99 0.6× 58 1.3k
M. Judith Radin United States 22 309 0.7× 235 1.0× 84 0.4× 120 0.6× 196 1.2× 62 1.5k
Zeki Yılmaz Türkiye 25 146 0.3× 181 0.7× 261 1.2× 93 0.5× 241 1.4× 119 1.5k
K. Georgilis Greece 11 103 0.2× 105 0.4× 192 0.9× 301 1.6× 375 2.2× 16 2.2k
Vivekanandhan Aravindhan India 18 66 0.1× 106 0.4× 154 0.7× 382 2.1× 277 1.7× 54 1.1k
Alex Chin Canada 19 205 0.5× 66 0.3× 197 0.9× 145 0.8× 84 0.5× 40 1.4k
Rajat Gupta India 17 65 0.1× 98 0.4× 208 0.9× 290 1.6× 161 1.0× 68 1.1k
L. Bæk Denmark 22 195 0.4× 241 1.0× 54 0.2× 479 2.6× 233 1.4× 46 1.7k
Daniel L. Chan United Kingdom 27 103 0.2× 201 0.8× 55 0.3× 116 0.6× 203 1.2× 79 1.7k

Countries citing papers authored by G Friman

Since Specialization
Citations

This map shows the geographic impact of G Friman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Friman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Friman more than expected).

Fields of papers citing papers by G Friman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Friman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Friman. The network helps show where G Friman may publish in the future.

Co-authorship network of co-authors of G Friman

This figure shows the co-authorship network connecting the top 25 collaborators of G Friman. A scholar is included among the top collaborators of G Friman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Friman. G Friman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lannergård, Anders, Anders Larsson, G Friman, & Uwe Ewald. (2008). Human serum amyloid A (SAA) and high sensitive C‐reactive protein (hsCRP) in preterm newborn infants with nosocomial infections. Acta Paediatrica. 97(8). 1061–1065. 14 indexed citations
2.
Lannergård, Anders, Anders Larsson, Peter Kragsbjerg, & G Friman. (2003). Correlations between serum amyloid A protein and C‐reactive protein in infectious diseases. Scandinavian Journal of Clinical and Laboratory Investigation. 63(4). 267–272. 55 indexed citations
3.
Henriksen, Egil, Tommy Jonason, Lars Wesslén, et al.. (2001). Thallium-201 Myocardial Imaging at Rest in Male Orienteers and Other Endurance Athletes. Upsala Journal of Medical Sciences. 106(1). 59–66. 2 indexed citations
4.
Lannergård, Anders, Jan Fohlman, Lars Wesslén, Christer Rolf, & G Friman. (2001). Immune function in Swedish élite orienteers. Scandinavian Journal of Medicine and Science in Sports. 11(5). 274–279. 3 indexed citations
5.
Holmberg, Martin, Stuart M. McGill, Lars Wesslén, et al.. (1999). Evaluation of Human Seroreactivity to Bartonella Species in Sweden. Journal of Clinical Microbiology. 37(5). 1381–1384. 30 indexed citations
6.
Friman, G & N.‐G. Ilbäck. (1998). Acute Infection: Metabolic Responses, Effects on Performance, Interaction with Exercise, and Myocarditis. International Journal of Sports Medicine. 19(S 3). S172–S182. 53 indexed citations
7.
Blomqvist, Gunilla, Lars Wesslén, Carl Påhlson, et al.. (1997). Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsis. Journal of Clinical Microbiology. 35(8). 1988–1995. 15 indexed citations
8.
Nilsson, Kenneth, Thomas G. T. Jaenson, Ingrid Uhnoo, et al.. (1997). Characterization of a spotted fever group Rickettsia from Ixodes ricinus ticks in Sweden. Journal of Clinical Microbiology. 35(1). 243–247. 54 indexed citations
9.
Henriksen, Egil, J Landelius, Lars Wesslén, et al.. (1996). Echocardiographic right and left ventricular measurements in male elite endurance athletes. European Heart Journal. 17(7). 1121–1128. 56 indexed citations
10.
Fohlman, Jan, et al.. (1993). High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis.. PubMed. 88. 103–8. 35 indexed citations
11.
Pauksen, Karlis, et al.. (1993). Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations.. PubMed. 88. 125–30. 13 indexed citations
12.
Frisk, Gun, Elin Nilsson, Torsten Tuvemo, G Friman, & Hans Diderholm. (1992). The possible role of Coxsackie A and echo viruses in the pathogenesis of type I diabetes mellitus studied by IgM analysis. Journal of Infection. 24(1). 13–22. 63 indexed citations
13.
Friman, G & N.‐G. Ilbäck. (1992). Exercise and infection – interaction, risks and benefits. Scandinavian Journal of Medicine and Science in Sports. 2(4). 177–189. 11 indexed citations
14.
Sjölin, Jan, H. Stjernström, G Friman, Jenny Larsson, & J. Wahren. (1990). Total and net muscle protein breakdown in infection determined by amino acid effluxes. American Journal of Physiology-Endocrinology and Metabolism. 258(5). E856–E863. 18 indexed citations
15.
Sjölin, Jan, H. Stjernström, G. Arturson, et al.. (1989). Exchange of 3-methylhistidine in the splanchnic region in human infection. American Journal of Clinical Nutrition. 50(6). 1407–1414. 20 indexed citations
16.
17.
Tuvemo, Torsten, Gun Frisk, G Friman, Johnny Ludvigsson, & Hans Diderholm. (1988). IgM against Coxsackie B viruses in children developing type I diabetes mellitus--a seven-year retrospective study.. PubMed. 9(3). 125–9. 11 indexed citations
18.
Nyström-Rosander, Christina, et al.. (1985). The First Human Case of Domestic Q Fever in Sweden. Acta Medica Scandinavica. 218(4). 429–432. 10 indexed citations
19.
Friman, G, et al.. (1983). Agranulocytosis associated with malaria prophylaxis with Maloprim.. BMJ. 286(6373). 1244–1245. 40 indexed citations
20.
Friman, G, N.‐G. Ilbäck, & Lars Pilström. (1981). Skeletal muscle lactate dehydrogenase isozymes and fibre composition in viral, mycoplasma and bacterial infections in young and old men. Scandinavian Journal of Clinical and Laboratory Investigation. 41(6). 551–556. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Göran Friman Breakdown of academic impact, for papers by Charles E. Wiedmeyer Breakdown of academic impact, for papers by M. Judith Radin Breakdown of academic impact, for papers by Zeki Yılmaz Breakdown of academic impact, for papers by K. Georgilis Breakdown of academic impact, for papers by Vivekanandhan Aravindhan Breakdown of academic impact, for papers by Alex Chin Breakdown of academic impact, for papers by Rajat Gupta Breakdown of academic impact, for papers by L. Bæk Breakdown of academic impact, for papers by Daniel L. Chan
Rankless by CCL
2026